NTHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NeOnc Technologies Holdings Inc (NTHI) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are neutral to slightly bearish, and there are no significant trading signals or positive trends in the stock's movement. While the company has promising developments in its clinical trials and a strong patent portfolio, its financial performance remains weak with negative net income and EPS. Additionally, there is no recent trading activity from insiders, hedge funds, or Congress to suggest confidence in the stock. Given the user's impatience and preference for long-term investments, this stock does not currently present a compelling opportunity.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 43.552, and moving averages are converging, showing no clear trend. The stock is trading below its pivot level of 9.655, with support at 9.026 and resistance at 10.284.
It also holds an extensive patent portfolio with protections until 2038.
The stock has a 50% chance of declining -0.59% in the next day and -2.38% in the next week. Financial performance remains weak with negative net income and EPS. No significant trading activity from insiders, hedge funds, or Congress.
In 2025/Q3, revenue remained at 0 with no growth. Net income improved by 294.41% YoY but remains negative at -8,615,920. EPS improved by 275% YoY but is still negative at -0.45. Gross margin is at 100%, but the company is not generating revenue.
No analyst rating or price target data is available.
